Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Effects of antibiotic physicochemical properties on their release kinetics from biodegradable polymer microparticles.

Shah SR, Henslee AM, Spicer PP, Yokota S, Petrichenko S, Allahabadi S, Bennett GN, Wong ME, Kasper FK, Mikos AG.

Pharm Res. 2014 Dec;31(12):3379-89. doi: 10.1007/s11095-014-1427-y. Epub 2014 May 30.

2.

Improved drug loading and antibacterial activity of minocycline-loaded PLGA nanoparticles prepared by solid/oil/water ion pairing method.

Kashi TS, Eskandarion S, Esfandyari-Manesh M, Marashi SM, Samadi N, Fatemi SM, Atyabi F, Eshraghi S, Dinarvand R.

Int J Nanomedicine. 2012;7:221-34. doi: 10.2147/IJN.S27709. Epub 2012 Jan 10.

3.

Evaluation of ciprofloxacin-loaded Eudragit RS100 or RL100/PLGA nanoparticles.

Dillen K, Vandervoort J, Van den Mooter G, Ludwig A.

Int J Pharm. 2006 May 11;314(1):72-82. Epub 2006 Apr 5.

PMID:
16600538
4.
5.

Controlled release of hyaluronan oligomers from biodegradable polymeric microparticle carriers.

Hedberg EL, Shih CK, Solchaga LA, Caplan AI, Mikos AG.

J Control Release. 2004 Nov 24;100(2):257-66.

PMID:
15544873
6.

PLGA-PEG microspheres of teverelix: influence of polymer type on microsphere characteristics and on teverelix in vitro release.

Mallardé D, Boutignon F, Moine F, Barré E, David S, Touchet H, Ferruti P, Deghenghi R.

Int J Pharm. 2003 Aug 11;261(1-2):69-80.

PMID:
12878396
7.
8.

Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer.

Lee WK, Park JY, Yang EH, Suh H, Kim SH, Chung DS, Choi K, Yang CW, Park JS.

J Control Release. 2002 Dec 5;84(3):115-23.

PMID:
12468215
10.

Ciprofloxacin-encapsulated poly(DL-lactide-co-glycolide) nanoparticles and its antibacterial activity.

Jeong YI, Na HS, Seo DH, Kim DG, Lee HC, Jang MK, Na SK, Roh SH, Kim SI, Nah JW.

Int J Pharm. 2008 Mar 20;352(1-2):317-23. Epub 2007 Nov 9.

PMID:
18160236
11.

Improvement of the antibacterial activity of daptomycin-loaded polymeric microparticles by Eudragit RL 100: an assessment by isothermal microcalorimetry.

Ferreira IS, Bettencourt A, Bétrisey B, Gonçalves LM, Trampuz A, Almeida AJ.

Int J Pharm. 2015 May 15;485(1-2):171-82. doi: 10.1016/j.ijpharm.2015.03.016. Epub 2015 Mar 12.

PMID:
25772414
12.

Preparation, characterization and in vitro cytotoxicity of indomethacin-loaded PLLA/PLGA microparticles using supercritical CO2 technique.

Kang Y, Wu J, Yin G, Huang Z, Yao Y, Liao X, Chen A, Pu X, Liao L.

Eur J Pharm Biopharm. 2008 Sep;70(1):85-97. doi: 10.1016/j.ejpb.2008.03.011. Epub 2008 Mar 29.

PMID:
18495445
13.

Degradable, antibiotic releasing poly(propylene fumarate)-based constructs for craniofacial space maintenance applications.

Henslee AM, Shah SR, Wong ME, Mikos AG, Kasper FK.

J Biomed Mater Res A. 2015 Apr;103(4):1485-97. doi: 10.1002/jbm.a.35288. Epub 2014 Aug 5.

PMID:
25046733
14.
16.

Unintended potential impact of perfect sink conditions on PLGA degradation in microparticles.

Klose D, Delplace C, Siepmann J.

Int J Pharm. 2011 Feb 14;404(1-2):75-82. doi: 10.1016/j.ijpharm.2010.10.054. Epub 2010 Nov 5.

PMID:
21056644
17.

Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.

Keohane K, Brennan D, Galvin P, Griffin BT.

Int J Pharm. 2014 Jun 5;467(1-2):60-9. doi: 10.1016/j.ijpharm.2014.03.051. Epub 2014 Mar 28.

PMID:
24680950
18.

Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles.

Misra R, Acharya S, Dilnawaz F, Sahoo SK.

Nanomedicine (Lond). 2009 Jul;4(5):519-30. doi: 10.2217/nnm.09.28.

PMID:
19572818
19.
20.

Factors affecting drug encapsulation and stability of lipid-polymer hybrid nanoparticles.

Cheow WS, Hadinoto K.

Colloids Surf B Biointerfaces. 2011 Jul 1;85(2):214-20. doi: 10.1016/j.colsurfb.2011.02.033. Epub 2011 Mar 2.

PMID:
21439797

Supplemental Content

Support Center